Financial Statements

FibroGen Inc (FGEN)

$ 18.57
-0.24 (-1.28%)
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in millions

Retained Earning Schedule

Year 2020 2019 2018 2017 2016 2015 2014 2013 2012
Retained Earnings (Previous Year) -785-716-596-470-408-322-263-248-
Net Income -189-77-86-126-62-86-60-15-33
Stock Dividends -8-33------215
Dividend Paid ---------
Retained Earnings -974-785-716-596-470-408-322-263-248

PPE Schedule

Year 2020 2019 2018 2017 2016 2015 2014 2013 2012
Gross PPE 82127129124129132130124-
Annual Depreciation -15-39614-4-11013124
Capital Expenditure -4-6-8-9-1-2-8-7-1
Net PPE 6382127129124129132130124

Intangible and Goodwill Schedule

Year 2020 2019 2018 2017 2016 2015 2014 2013 2012
Intangible and Goodwill (Previous Year) ---------
New Purchases -2--145-42-9-0-577-411-8
Intangible and Goodwill ---------

FibroGen Inc income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes FibroGen Inc FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.